Microbiome Conferences
Recent regulatory approvals and pivotal clinical results represent important milestones in the long term safety and efficacy of microbiome-based therapies.
With over 50 new clinical trials initiated in the past 12 months, and new research programs leveraging novel microbiome-based technologies and biomarkers, access the insight you need to make better microbiome-based drug development decisions.